$30 Billion Deal, page-4065

BIT225 TRIAL RESULTS SHOW EFFECTIVE CURE OF HEPATITIS C
Biotron, a small drug discovery company based in Australia Listed on the ASX as BIT and USA as BITRF , and has announced the discovery of a potential cure for COVID-19. The drug, called BIT225, is a small molecule that blocks the replication of the SARS-CoV-2 virus, which causes COVID-19.
BIT225 works by targeting two proteins that are essential for the virus to replicate: Vpu and Env. Vpu is a protein that helps the virus to evade the host's immune system, while Env is a protein that helps the virus to enter host cells. By blocking these two proteins, BIT225 can effectively prevent the virus from replicating and spreading .
This means Cure Crmbo in Mice :

. BIT225 treatment wasassociated with potentsuppression of virus load, and reduced inflammation markers, consistent with effectiveclearance of the virus.